<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?DTDIdentifier.IdentifierValue article.dtd?><?DTDIdentifier.IdentifierType system?><?SourceDTD.DTDName article.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName bmc2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Respir Res</journal-id><journal-title-group><journal-title>Respiratory Research</journal-title></journal-title-group><issn pub-type="ppub">1465-9921</issn><issn pub-type="epub">1465-993X</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1465-9921-10-114</article-id><article-id pub-id-type="pmid">19930563</article-id><article-id pub-id-type="doi">10.1186/1465-9921-10-114</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Role of lysophosphatidic acid receptor LPA<sub>2 </sub>in the development of allergic airway inflammation in a murine model of asthma</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="A1"><name><surname>Zhao</surname><given-names>Yutong</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>yzhao@medicine.bsd.uchicago.edu</email></contrib><contrib contrib-type="author" id="A2"><name><surname>Tong</surname><given-names>Jiankun</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>jtong@bsd.uchicago.edu</email></contrib><contrib contrib-type="author" id="A3"><name><surname>He</surname><given-names>Donghong</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>dhe@medicine.bsd.uchicago.edu</email></contrib><contrib contrib-type="author" id="A4"><name><surname>Pendyala</surname><given-names>Srikanth</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>spendyala@medicine.bsd.uchicago.edu</email></contrib><contrib contrib-type="author" id="A5"><name><surname>Evgeny</surname><given-names>Berdyshev</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>eberdysh@medicine.bsd.uchicago.edu</email></contrib><contrib contrib-type="author" id="A6"><name><surname>Chun</surname><given-names>Jerold</given-names></name><xref ref-type="aff" rid="I2">2</xref><email>jchun@scripps.edu</email></contrib><contrib contrib-type="author" id="A7"><name><surname>Sperling</surname><given-names>Anne I</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>asperlin@medicine.bsd.uchicago.edu</email></contrib><contrib contrib-type="author" id="A8"><name><surname>Natarajan</surname><given-names>Viswanathan</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>vnataraj@medicine.bsd.uchicago.edu</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of Medicine, The University of Chicago, Chicago, Illinois, USA</aff><aff id="I2"><label>2</label>Department of Molecular Biology, The Scripps Research Institute, La Jolla, California, USA</aff><pub-date pub-type="ppub"><year>2009</year></pub-date><pub-date pub-type="epub"><day>20</day><month>11</month><year>2009</year></pub-date><volume>10</volume><issue>1</issue><fpage>114</fpage><lpage>114</lpage><history><date date-type="received"><day>28</day><month>5</month><year>2009</year></date><date date-type="accepted"><day>20</day><month>11</month><year>2009</year></date></history><permissions><copyright-statement>Copyright &#x000a9;2009 Zhao et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2009</copyright-year><copyright-holder>Zhao et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:href="http://respiratory-research.com/content/10/1/114"/><abstract><sec><title>Background</title><p>Lysophosphatidic acid (LPA) plays a critical role in airway inflammation through G protein-coupled LPA receptors (LPA<sub>1-3</sub>). We have demonstrated that LPA induced cytokine and lipid mediator release in human bronchial epithelial cells. Here we provide evidence for the role of LPA and LPA receptors in Th2-dominant airway inflammation.</p></sec><sec><title>Methods</title><p>Wild type, LPA<sub>1 </sub>heterozygous knockout mice (LPA<sub>1</sub><sup>+/-</sup>), and LPA<sub>2 </sub>heterozygous knockout mice (LPA<sub>2</sub><sup>+/-</sup>) were sensitized with inactivated <italic>Schistosoma mansoni </italic>eggs and local antigenic challenge with <italic>Schistosoma mansoni </italic>soluble egg Ag (SEA) in the lungs. Bronchoalveolar larvage (BAL) fluids and lung tissues were collected for analysis of inflammatory responses. Further, tracheal epithelial cells were isolated and challenged with LPA.</p></sec><sec><title>Results</title><p>BAL fluids from <italic>Schistosoma mansoni </italic>egg-sensitized and challenged wild type mice (4 days of challenge) showed increase of LPA level (~2.8 fold), compared to control mice. LPA<sub>2</sub><sup>+/- </sup>mice, but not LPA<sub>1</sub><sup>+/- </sup>mice, exposed to <italic>Schistosoma mansoni </italic>egg revealed significantly reduced cell numbers and eosinophils in BAL fluids, compared to challenged wild type mice. Both LPA<sub>2</sub><sup>+/- </sup>and LPA<sub>1</sub><sup>+/- </sup>mice showed decreases in bronchial goblet cells. LPA<sub>2</sub><sup>+/- </sup>mice, but not LPA<sub>1</sub><sup>+/- </sup>mice showed the decreases in prostaglandin E2 (PGE2) and LPA levels in BAL fluids after SEA challenge. The PGE2 production by LPA was reduced in isolated tracheal epithelial cells from LPA<sub>2</sub><sup>+/- </sup>mice. These results suggest that LPA and LPA receptors are involved in <italic>Schistosoma mansoni </italic>egg-mediated inflammation and further studies are proposed to understand the role of LPA and LPA receptors in the inflammatory process.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>Lysophosphatidic acid (LPA) is a naturally occurring bioactive lysophospholipid and is a component of plasma, biological fluids, and tissues [<xref ref-type="bibr" rid="B1">1</xref>-<xref ref-type="bibr" rid="B3">3</xref>]. Many of the biological responses of LPA such as cell proliferation [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>], migration [<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B7">7</xref>], and cytokine release [<xref ref-type="bibr" rid="B8">8</xref>-<xref ref-type="bibr" rid="B10">10</xref>] are mediated by a family of G-protein coupled receptors (GPCRs). At least six LPA receptors, LPA<sub>1-6</sub>, have been cloned and described in mammals, and the biological effects of LPA are mediated by ligation to specific LPA receptors that are coupled to heterotrimeric G-protein families, the G<sub>s</sub>, G<sub>i</sub>, G<sub>q</sub>, and G<sub>12/13 </sub>[<xref ref-type="bibr" rid="B11">11</xref>-<xref ref-type="bibr" rid="B17">17</xref>].</p><p>The role of LPA and LPA receptors in airway inflammatory diseases have been studied <italic>in vitro </italic>and <italic>in vivo</italic>. LPA is a potent stimulator of interleukin-8 (IL-8) secretion in primary cultured human bronchial epithelial cells (HBEpCs) [<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B10">10</xref>], and is a mitogen for airway smooth muscle cells [<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B19">19</xref>]. Intratracheal administration of LPA in mice increased MIP-2 levels at 3 h and neutrophil infiltration at 6 h [<xref ref-type="bibr" rid="B20">20</xref>]. Inhalation of LPA induced histamine release and enhanced the recruitment eosinophils and neutrophils to the guinea pig lung alveolar space [<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B22">22</xref>]. While these studies suggest that LPA regulates airway inflammation via stimulating the release of cytokines and inflammatory mediators that modulate infiltration of neutrophils and eosinophils into the airway, others point out that LPA exhibits anti-inflammatory effects and promotes resolution of inflammation. In human bronchial epithelial cells, LPA induced IL-13 decoy receptor, IL-13R&#x003b1;2 expression and release, and attenuated IL-13-induced phosphorylation of STAT6 [<xref ref-type="bibr" rid="B9">9</xref>]. Further, LPA enhanced cyclooxygenase-2 (COX-2) expression and prostaglandin E2 (PGE2) release in HBEpCs [<xref ref-type="bibr" rid="B23">23</xref>] suggesting a protective role in the innate immunity response and tissue repair process in airway inflammation [<xref ref-type="bibr" rid="B24">24</xref>,<xref ref-type="bibr" rid="B25">25</xref>]. Recently, Fan et al. showed that intravenous injection with LPA attenuated bacterial endotoxin-induced plasma TNF-&#x003b1; production and myeloperoxidase activity in mouse lung, suggesting an anti-inflammatory role of LPA in a murine model of acute lung injury [<xref ref-type="bibr" rid="B26">26</xref>]. In addition to its anti-inflammatory effect, LPA regulated E-cadherin intracellular trafficking and airway epithelial barrier integrity and intratracheal post-treatment with LPA reduced neutrophil influx, protein leak, and E-cadherin shedding in bronchoalveolar lavage (BAL) fluids in a murine model of LPS-induced acute lung injury [<xref ref-type="bibr" rid="B27">27</xref>]. These data suggest a protective role of administrated LPA in airway inflammatory diseases.</p><p>In contrast to several <italic>in vitro </italic>studies on the role of LPA as a pro- or anti-inflammatory mediator in airway epithelial and smooth muscle cells [<xref ref-type="bibr" rid="B8">8</xref>,<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B18">18</xref>-<xref ref-type="bibr" rid="B20">20</xref>], there are a few reports linking LPA levels and LPA receptors to airway or lung inflammation and injury. We have recently shown that LPA was constitutively present in BAL fluids from normal and asthmatic subjects and segmental allergen challenge increased LPA levels in BAL fluids significantly [<xref ref-type="bibr" rid="B28">28</xref>]. However, the source of LPA and the pathophysiological relevance of increased LPA after segmental allergen challenge to allergic inflammation remain to be elucidated. Similarly, LPA levels in BAL fluids from individuals with idiopathic pulmonary fibrosis were significantly higher compared to normal controls [<xref ref-type="bibr" rid="B29">29</xref>]. Further, an increase in LPA levels in BAL fluid following lung injury was observed in the bleomycin model of pulmonary fibrosis, and mice lacking LPA<sub>1 </sub>were protected from fibrosis and mortality [<xref ref-type="bibr" rid="B29">29</xref>]. These studies suggest a role for LPA receptors in linking lung injury in the murine bleomycin model of pulmonary fibrosis.</p><p>Asthma is a chronic inflammatory disease of the airways involving T-lymphocytes and eosinophils infiltration, mucus overproduction and airway hyper-responsiveness. Inflammatory mediators including lipid mediators play a critical role in the pathogenesis of chronic airway diseases and facilitate the recruitment, activation, and trafficking of inflammatory cells in the airways. Very little is known on the physiological consequences of increased LPA levels and role of LPA receptors in asthma. To address the role of LPA receptors in Th2-mediated inflammation, we have used a well described <italic>Schistosoma mansoni </italic>eggs-sensitized murine model of allergic airway inflammation [<xref ref-type="bibr" rid="B30">30</xref>-<xref ref-type="bibr" rid="B32">32</xref>]. Control wild type, <italic>LPA</italic><sub>1</sub><sup>+/- </sup>and <italic>LPA</italic><sub>2</sub><sup>+/- </sup>mice were sensitized and challenged with <italic>Schistosoma mansoni </italic>eggs. LPA<sub>2</sub><sup>+/- </sup>challenged mice compared to wild type showed decrease in cell numbers, eosinophils, and positive PAS staining. Interestingly, only <italic>Schistosoma mansoni </italic>eggs sensitized and challenged <italic>LPA</italic><sub>2</sub><sup>+/-</sup>, but not <italic>LPA</italic><sub>1</sub><sup>+/-</sup>, mice showed reduced PGE2 levels in BAL fluids which correlated with diminished COX-2 expression in LPA<sub>2</sub><sup>+/- </sup>mice. Furthermore, airway epithelial cells isolated from <italic>LPA</italic><sub>2</sub><sup>+/- </sup>mice exhibited reduced COX-2 expression and PGE2 release compared to cells from wild type mice. These results show for the first time a role for LPA<sub>2 </sub>in the development of airway inflammation and pathogenesis of asthma.</p></sec><sec sec-type="materials|methods"><title>Materials and methods</title><sec><title>Animals</title><p>All the mice were bred and housed in a specific pathogen-free barrier facility maintained by the University of Chicago Animal Resources Center. The studies reported here conform to the principles outlined by the Animal Welfare Act and the National Institutes of Health guidelines for the care and use of animals in biomedical research.</p></sec><sec><title>PCR genotyping of LPA<sub>1</sub><sup>+/- </sup>and LPA<sub>2</sub><sup>+/- </sup>mice</title><p>Extract-N-Amp Tissue PCR kit (Sigma Aldrich, S. Louis) was utilized for isolating genomic DNA from mouse tail and amplifying DNA fragments. The primers for LPA<sub>1 </sub>and LPA<sub>2 </sub>knockout mice were described as previous studies [<xref ref-type="bibr" rid="B33">33</xref>,<xref ref-type="bibr" rid="B34">34</xref>].</p></sec><sec><title><italic>Schistosoma mansoni </italic>eggs sensitization and challenge</title><p><italic>Schistosoma mansoni </italic>eggs sensitization and challenge to induce murine allergic airway disease were described before [<xref ref-type="bibr" rid="B31">31</xref>]. In brief, at day 0, mice (6-8 weeks) were immunized by i.p. injection of 5,000 inactivated <italic>Schistosoma mansoni </italic>eggs. At day 7, the mice were challenged with 10 &#x003bc;g of SEA by intratracheal aspiration. The mice were studied at day 11.</p></sec><sec><title>Analyses of BAL fluids</title><p>BAL fluids were performed by an intratracheal injection of 1 ml of PBS solution followed by gentle aspiration. The lavage was repeated twice to recover a total volume of 1.8-2.0 ml. The lavage was centrifuged and supernatant was processed for PGE2 or LPA measurement. The percentages of cell types in BAL fluids were determined by FACS analysis with cell type-specific markers.</p></sec><sec><title>Histology</title><p>Lungs were removed from mice and lobes were sectioned sagitally, embedded in paraffin, cut into 5-&#x003bc;m sections. Periodic Acid Schiff (PAS) staining were performed by Pathology Core Facility in The University of Chicago.</p></sec><sec><title>Antibodies and flow cytometry</title><p>Antibody to mouse CCR3 (clone 831101.111) was obtained from R&#x00026;D Systems (Minneapolis, MN). Cells were fixed with 4% paraformaldehyde for 10 min and incubated with staining antibodies for 30 min at 4&#x000b0;C. The samples were washed and analyzed on a FACS LSR-II (Becton Dickinson).</p></sec><sec><title>Isolation of tracheal epithelial cells</title><p>Briefly, mice were euthanized and their tracheas were isolated and digested with 0.1% protease (Type XIV, Sigma) overnight at 4&#x000b0;C. The tracheal cell suspension were transferred to 15 ml tube and spun at 1500 rpm for 3 min at 4&#x000b0;C and were pooled in BEGM medium (Lonza, Walkersville, MD).</p></sec><sec><title>LPA measurement by mass spectrometry</title><p>Lipids in BAL were extracted as described before [<xref ref-type="bibr" rid="B28">28</xref>]. In brief, LPA levels were determined using liquid chromatography and tandem mass spectrometry (LC) with ABI-4000 Q-TRAP hybrid triple quadrupole/ion trap mass spectrometer (MS) coupled with an Agilent 1100 liquid chromatography system. Lipids were separated using methanol/water/HCOOH, 79/20/0.5, v/v, with 5 mM NH4COOH as solvent A and methanol/acetonitrile/HCOOH, 59/40/0.5, v/v, with 5 mM NH4COOH as Solvent B. LPA molecular species were analyzed in negative ionization mode with declustering potential and collision energy optimized for LPA.</p></sec><sec><title>PGE2 measurement</title><p>Mouse tracheal epithelial cells grown on 6-well plates were challenged with LPA for 3 h, medium were collected and centrifuged at 5,000 &#x000d7; g for 10 min at 4&#x000b0;C. The supernatant or BAL fluid supernatant were transferred to new 2.0 ml-eppendorf tubes and frozen in -80&#x000b0;C for later analysis. Measurement of PGE2 levels, as 13, 14-dihydro-15-keto PGE2, was carried out using a commercial ELISA kit according to manufacture's instruction.</p></sec><sec><title>RNA isolation and Real-time RT-PCR</title><p>Total RNA was isolated from cultured mouse tracheal epithelial cells using TRIzol<sup>&#x000ae; </sup>reagent (Life Technology, Rockville, MD) according to the manufacturer's instructions. RNA was quantified spectrophotometrically and 1 &#x003bc;g of RNA was reversed transcripted using cDNA synthesis kit (Bio-Rad) and Real-time PCR and quantitative PCR were performed to assess expression of the COX-2, LPA<sub>1</sub>, LPA<sub>2</sub>, LPA<sub>3</sub>, LPA<sub>4</sub>, and LPA<sub>5 </sub>using primers designed based on mouse mRNA sequences (Table <xref ref-type="table" rid="T1">1</xref>.). Amplicon expression in each sample was normalized to its 18S RNA content. The relative abundance of target mRNA in each sample was calculated as 2 raised to the negative of its threshold cycle value times 10<sup>6 </sup>after being normalized to the abundance of its corresponding 18S, [e.g., 2 <sup>-(Target Gene Threshold Cycle)</sup>/2 <sup>-(18S Threshold Cycle) </sup>&#x000d7; 10<sup>6</sup>].</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Primers for mouse LPA receptors and COX-2</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">LPA<sub>1</sub></th><th align="left">Forward: 5'-TCAACCTGGTGACCTTTGTG-3'<break/>Reverse: 5'-GGTCCAGAACTATGCCGAGA-3'</th></tr></thead><tbody><tr><td align="left">LPA<sub>2</sub></td><td align="left">Forward: 5'-ATATTCCTGCCGAGATGCTG-3'<break/>Reverse: 5'-AAGCTGAGTAACGGGCAGAC-3'</td></tr><tr><td colspan="2"><hr/></td></tr><tr><td align="left">LPA<sub>3</sub></td><td align="left">Forward: 5'-ATTGCCTCTGCAACATCTCG-3'<break/>Reverse: 5'-ATGAAGAAGGCCAGGAGGTT-3'</td></tr><tr><td colspan="2"><hr/></td></tr><tr><td align="left">LPA<sub>4</sub></td><td align="left">Forward: 5'-ACTGCGTTCCTCACCAACAT-3'<break/>Reverse: 5'-CGATCGGAAGGGATAGACAA-3'</td></tr><tr><td colspan="2"><hr/></td></tr><tr><td align="left">LPA<sub>5</sub></td><td align="left">Forward: 5'-GCTCCAGTGCCCTGACTATC-3'<break/>Reverse: 5'-CAGAGCGTTGAGAGGGAGAC-3'</td></tr><tr><td colspan="2"><hr/></td></tr><tr><td align="left">COX-2</td><td align="left">Forward: 5'-CCCCCACAGTCAAAGACACT-3'<break/>Reverse: 5'-GGCACCAGACCAAAGACTTC-3'</td></tr></tbody></table></table-wrap></sec><sec><title>Western blotting</title><p>Equal amounts of protein (20 &#x003bc;g) were subjected to 10% SDS/PAGE gels, transferred to polyvinylidene difluoride membranes, blocked with 5% (w/v) BSA in TBST (25 mM Tris-HCl, pH 7.4, 137 mM NaCl and 0.1% Tween-20) for 1 h and incubated with anti-COX-2 antibody in 5% (w/v) BSA in TBST for 1-2 h at room temperature. The membranes were washed at least three times with TBST at 15 min intervals and then incubated with a rabbit horseradish peroxidase-conjugated secondary antibody (1: 3,000) for 1 h at room temperature. The membrane was developed with enhanced chemiluminescence detection system according to Manufacturer's instructions.</p></sec><sec><title>Statistical analysis</title><p>All results were subjected to statistical analysis using one-way ANOVA and, whenever appropriate, analyzed by Student-Newman-Keuls test. Data are expressed as means &#x000b1; S.D. of triplicate samples from at least three independent experiments and level of significance was taken to P &#x0003c; 0.05.</p></sec></sec><sec><title>Results</title><sec><title><italic>Schistosoma mansoni </italic>eggs sensitization and challenge increases LPA levels in BAL fluids</title><p>To investigate the role of LPA receptors in pathogenesis of asthma, we quantified LPA levels in BAL fluids from control and SEA-challenged mice. Mice were sensitized by i.p. injection of 5,000 inactivated <italic>Schistosoma mansoni </italic>eggs. At day 7, mice were challenged with or without 10 &#x003bc;g of SEA by intratracheal aspiration and at day 11, BAL fluids were collected (Fig. <xref ref-type="fig" rid="F1">1</xref>) and lipid were extracted and LPA levels in BAL fluids were measured by LC-MS/MS with C17:0 LPA as an internal standard. As shown in Table <xref ref-type="table" rid="T2">2</xref>, LPA was detectable (~1254.3 &#x000b1; 357.0 pmole/ml) in control mice (sensitized with inactivated <italic>Schistosoma mansoni </italic>eggs but not SEA challenged), and there was a ~2.8 fold increase in LPA levels (~3557.9 &#x000b1; 109.3 pmole/ml) in <italic>Schistosoma mansoni </italic>eggs sensitized and challenged mice, compared to control mice. Unsaturated molecular species of LPA (18:1, 20:4, 22:5, and 22:6) were detected in BAL fluids of control mice, which increased significantly after SEA challenge. These results show for the first time, to our knowledge, increase in LPA during allergic lung inflammation in a murine model of asthma.</p><fig id="F1" position="float"><label>Figure 1</label><caption><p><bold><italic>Schistosoma mansoni </italic>eggs sensitization and challenge induces murine asthmatic model</bold>. At day 0, mice (6-8 weeks) were immunized by i.p. injection of 5,000 inactivated <italic>Schistosoma mansoni </italic>eggs. At day 7, mice were challenged with 10 &#x003bc;g of SEA by intratracheal aspiration. Lung tissues and BAL fluids were collected at day 11.</p></caption><graphic xlink:href="1465-9921-10-114-1"/></fig><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Quatification of LPA molecular species in BAL fluids</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">LPA molecular species</th><th align="center">Wt sensitization only (pmol/ml)</th><th align="center">Wt sensitization and SEA challenged (pmol/ml)</th></tr></thead><tbody><tr><td align="left">14:0-LPA</td><td align="center">5.6 &#x000b1; 3.1</td><td align="center">14.6 &#x000b1; 1.2</td></tr><tr><td colspan="3"><hr/></td></tr><tr><td align="left">16:1-LPA</td><td align="center">50.4 &#x000b1; 37.0</td><td align="center">160.9 &#x000b1; 3.7</td></tr><tr><td colspan="3"><hr/></td></tr><tr><td align="left">16:0-LPA</td><td align="center">88.4 &#x000b1; 51.7</td><td align="center">253.6 &#x000b1; 10.8</td></tr><tr><td colspan="3"><hr/></td></tr><tr><td align="left">18:2-LPA</td><td align="center">83.9 &#x000b1; 54.6</td><td align="center">274.4 &#x000b1; 7.0</td></tr><tr><td colspan="3"><hr/></td></tr><tr><td align="left">18:1-LPA</td><td align="center">154.3 &#x000b1; 114.7</td><td align="center">517.6 &#x000b1; 17.9</td></tr><tr><td colspan="3"><hr/></td></tr><tr><td align="left">18:0-LPA</td><td align="center">54.9 &#x000b1; 27.4</td><td align="center">153.7 &#x000b1; 8.0</td></tr><tr><td colspan="3"><hr/></td></tr><tr><td align="left">20:5-LPA</td><td align="center">26.7 &#x000b1; 22.0</td><td align="center">95.7 &#x000b1; 1.9</td></tr><tr><td colspan="3"><hr/></td></tr><tr><td align="left">20:4-LPA</td><td align="center">212.9 &#x000b1; 168.2</td><td align="center">739.0 &#x000b1; 23.1</td></tr><tr><td colspan="3"><hr/></td></tr><tr><td align="left">20:3-LPA</td><td align="center">51.7 &#x000b1; 39.8</td><td align="center">165.2 &#x000b1; 5.5</td></tr><tr><td colspan="3"><hr/></td></tr><tr><td align="left">20:2-LPA</td><td align="center">4.7 &#x000b1; 3.4</td><td align="center">14.1 &#x000b1; 0.8</td></tr><tr><td colspan="3"><hr/></td></tr><tr><td align="left">22:6-LPA</td><td align="center">189.4 &#x000b1; 114.4</td><td align="center">548.9 &#x000b1; 18.1</td></tr><tr><td colspan="3"><hr/></td></tr><tr><td align="left">22:5-LPA</td><td align="center">291.6 &#x000b1; 166.2</td><td align="center">576.9 &#x000b1; 22.2</td></tr><tr><td colspan="3"><hr/></td></tr><tr><td align="left">22:4-LPA</td><td align="center">16.8 &#x000b1; 9.5</td><td align="center">41.1 &#x000b1; 1.5</td></tr><tr><td colspan="3"><hr/></td></tr><tr><td align="left">22:3-LPA</td><td align="center">0.7 &#x000b1; 0.6</td><td align="center">1.9 &#x000b1; 0.5</td></tr><tr><td colspan="3"><hr/></td></tr><tr><td align="left">22:2-LPA</td><td align="center">0.2 &#x000b1; 0.1</td><td align="center">0.2 &#x000b1; 0.1</td></tr><tr><td colspan="3"><hr/></td></tr><tr><td align="left">Total LPA</td><td align="center">1254.3 &#x000b1; 357.0</td><td align="center">3557.9 &#x000b1; 109.3</td></tr></tbody></table><table-wrap-foot><p>BAL fluids were collected and lipis were extracted. LPA molecular species were quantified by LC-MS/MS with 17:0LPA as standard.</p></table-wrap-foot></table-wrap></sec><sec><title><italic>Schistosoma mansoni </italic>eggs sensitization and challenge-induced airway inflammation is dependent on LPA<sub>1 </sub>and LPA<sub>2</sub></title><p>To determine the role of LPA receptors in airway inflammation mediated by <italic>Schistosoma mansoni </italic>eggs sensitization and challenge, we used LPA<sub>1 </sub>and LPA<sub>2 </sub>deficient mice, which were genetically engineered as described earlier [<xref ref-type="bibr" rid="B33">33</xref>,<xref ref-type="bibr" rid="B34">34</xref>]. The heterozygous LPA<sub>1</sub><sup>+/- </sup>and LPA<sub>2</sub><sup>+/- </sup>mice were housed and bred at the University of Chicago Animal Resources Center and described experiments were approved by the ACIU of the University of Chicago. Genotyping analyses with specific primers confirmed generation of wild type (+/+), heterozygous (+/-) and homozygous mice (-/-) from the genetically engineered LPA<sub>1 </sub>and LPA<sub>2 </sub>mice (data not shown). Since LPA<sub>1</sub><sup>-/- </sup>showed 50% neonatal lethality and impaired sucking in neonatal pups, all experiments were carried out with LPA<sub>1</sub><sup>+/- </sup>and LPA<sub>2</sub><sup>+/- </sup>mice to investigate the role of LPA receptors in <italic>Schistosoma mansoni </italic>eggs sensitization and challenge-mediated allergic inflammatory responses. To determine whether LPA<sub>1</sub><sup>+/- </sup>and LPA<sub>2</sub><sup>+/- </sup>mice reduced the effect of LPA, wild type, LPA<sub>1</sub><sup>+/- </sup>and LPA<sub>2</sub><sup>+/- </sup>mice were intratracheal challenged with 18:1LPA (5 &#x003bc;M in 25 &#x003bc;l PBS) for 6 h. As shown in Fig. <xref ref-type="fig" rid="F2">2</xref>, LPA challenge increased neutrophil infiltration, however, LPA<sub>1</sub><sup>+/- </sup>and LPA<sub>2</sub><sup>+/- </sup>mice reduced LPA-induced neutrophil infiltration in BAL fluids, suggesting that less LPA<sub>1 </sub>and LPA<sub>2 </sub>receptors in LPA<sub>1</sub><sup>+/- </sup>and LPA<sub>2</sub><sup>+/- </sup>mice reduce LPA-induced inflammation in lung and that LPA<sub>1</sub><sup>+/- </sup>and LPA<sub>2</sub><sup>+/- </sup>mice are useful models for investigating role of LPA receptors in lung inflammatory diseases.</p><fig id="F2" position="float"><label>Figure 2</label><caption><p><bold>LPA<sub>1</sub><sup>+/- </sup>and LPA<sub>2</sub><sup>+/- </sup>mice show reduced neutrophils infiltration to BAL fluids</bold>. 18:1LPA (5 &#x003bc;M in 25 &#x003bc;l PBS) were intratracheally injected to wild type, LPA<sub>1</sub><sup>+/-</sup>, and LPA<sub>2</sub><sup>+/- </sup>mice (n = 4-5) for 6 h. BAL fluids were collected and percentage of neutrophils in total cells were examined by Cytospin.</p></caption><graphic xlink:href="1465-9921-10-114-2"/></fig><p>Wild type, LPA<sub>1</sub><sup>+/-</sup>, and LPA<sub>2</sub><sup>+/- </sup>mice were sensitized with inactivated <italic>Schistosoma mansoni </italic>eggs and challenged with or without SEA for 4 days, BAL fluids and lung tissues were collected, cell numbers were measured under microscope and total eosinophils were determined by flow cytometry using eosinophils specific antibody (anti-CCR3). Consistent with pervious reports [<xref ref-type="bibr" rid="B30">30</xref>,<xref ref-type="bibr" rid="B32">32</xref>], <italic>Schistosoma mansoni </italic>eggs sensitized and challenged wild type mice showed significant increase in total cell numbers and eosinophils in BAL fluids; however, total cell numbers and recruitment of eosinophils were attenuated in LPA<sub>2</sub><sup>+/-</sup>, but not LPA<sub>1</sub><sup>+/- </sup>mice (Fig. <xref ref-type="fig" rid="F3">3</xref>). These results suggest a role for LPA<sub>2 </sub>in influx of eosinophils into alveolar space during allergic inflammatory response.</p><fig id="F3" position="float"><label>Figure 3</label><caption><p><bold>LPA<sub>2</sub><sup>+/- </sup>mice exhibit a decrease in cell numbers and eosinophils in BAL fluids</bold>. After wild type, LPA<sub>1</sub><sup>+/-</sup>, and LPA<sub>2</sub><sup>+/- </sup>mice (n = 4-6) were challenged with or without <italic>Schistosoma mansoni </italic>eggs at day 11, as described in Materials and Methods, BAL fluids were collected and total cell numbers were accounted <bold>(A)</bold>. Eosinophil numbers were examined by flow cytometry with antibody to CCR3 <bold>(B)</bold>.</p></caption><graphic xlink:href="1465-9921-10-114-3"/></fig><p>Airway goblet cell metaplasia and mucus production, indices of degree of inflammation, are hallmarks of asthma. Goblet cell metaplasia and mucus production were determined by PAS staining of histological sections of lung tissues from <italic>Schistosoma mansoni </italic>eggs sensitized and challenged or non-challenged wild type, LPA<sub>1</sub><sup>+/-</sup>, and LPA<sub>2</sub><sup>+/- </sup>mice. As shown in Fig. <xref ref-type="fig" rid="F4">4A</xref>, PAS positive goblet cells were higher in <italic>Schistosoma mansoni </italic>eggs sensitized and challenged wild type mice, compared to <italic>Schistosoma mansoni </italic>eggs sensitized and non-challenged wild type mice (control mice), whereas significantly less PAS stained goblet cells were seen in <italic>Schistosoma mansoni </italic>eggs sensitized and challenged LPA<sub>1</sub><sup>+/- </sup>and LPA<sub>2</sub><sup>+/- </sup>mice, compared to <italic>Schistosoma mansoni </italic>eggs sensitized and challenged wild type mice. Scoring of the histological sections also confirmed a significantly higher percentage of bronchi for PAS positive stained cells in the sensitized and challenged control wild type mice compared to LPA<sub>1</sub><sup>+/- </sup>and LPA<sub>2</sub><sup>+/- </sup>mice (Fig. <xref ref-type="fig" rid="F4">4B</xref>). These results demonstrate that <italic>Schistosoma mansoni </italic>eggs sensitized and challenged LPA<sub>1</sub><sup>+/- </sup>and LPA<sub>2</sub><sup>+/- </sup>mice develop reduced goblet cell metaplasia and mucus production compared to control wild type mice. Together, these data suggest a role for LPA receptors for optimal induction of Th2-mediated airway inflammation.</p><fig id="F4" position="float"><label>Figure 4</label><caption><p><bold>LPA<sub>1</sub><sup>+/- </sup>and LPA<sub>2</sub><sup>+/- </sup>mice exhibit decreases in goblet cells</bold>. <bold>A) </bold>Representative PAS staining sections from <italic>Schistosoma mansoni </italic>eggs unchallenged and challenged wild type, LPA<sub>1</sub><sup>+/-</sup>, and LPA<sub>2</sub><sup>+/- </sup>mice (n = 4-6) are shown. <bold>B) </bold>Percentage of PAS positive goblet cells in each bronchia (n = 3-5) were calculated.</p></caption><graphic xlink:href="1465-9921-10-114-4"/></fig></sec><sec><title>LPA<sub>2</sub><sup>+/-</sup>, but not LPA<sub>1</sub><sup>+/-</sup>, mice exhibit reduced LPA and PGE2 levels in BAL fluids, and COX-2 expression in lungs of <italic>Schistosoma mansoni </italic>eggs sensitized/challenged mice</title><p>Endogenous PGE2 is produced by airway epithelium, smooth muscle, dendritic cells, and macrophages in response to allergen challenge [<xref ref-type="bibr" rid="B35">35</xref>]. PGE2 has been shown to be an anti-inflammatory lipid mediator and bronchodilator in the airway [<xref ref-type="bibr" rid="B24">24</xref>,<xref ref-type="bibr" rid="B25">25</xref>]; however, administration of PGE2 induced various side effects, including cough, enhanced mucus production, and sensory nerve stimulation [<xref ref-type="bibr" rid="B36">36</xref>]. To determine the role of LPA receptors expression and PGE2 production in response to allergen challenge, we analyzed PGE2 levels in BAL fluids and COX-2 expression in lung tissues from <italic>Schistosoma mansoni </italic>eggs sensitized and challenged wild type mice. As shown in Fig. <xref ref-type="fig" rid="F5">5A</xref>, PGE2 levels were higher in control wild type and LPA<sub>1</sub><sup>+/- </sup>mice, compared to LPA<sub>2</sub><sup>+/- </sup>mice in response to <italic>Schistosoma mansoni </italic>eggs sensitization and challenge. <italic>Schistosoma mansoni </italic>eggs sensitization and challenge increased COX-2 expression in lung tissues of wild type mice while LPA<sub>2</sub><sup>+/- </sup>mice showed reduced COX-2 expression (Fig. <xref ref-type="fig" rid="F5">5B</xref>). Recently, we have shown that LPA induces COX-2 expression and PGE2 release in human bronchial epithelial cells [<xref ref-type="bibr" rid="B23">23</xref>]. As <italic>Schistosoma mansoni </italic>eggs sensitization and challenge increased LPA levels in BAL fluids (Table <xref ref-type="table" rid="T2">2</xref>), we measured LPA levels in BAL fluids from sensitized and SEA challenged LPA<sub>2</sub><sup>+/- </sup>mice. Compared to wild type mice, LPA levels in BAL fluids from LPA<sub>2</sub><sup>+/- </sup>mice were decreased after SEA challenge. Together, these results suggest that increased lung COX-2 expression, PGE2 and LPA production in BAL fluids by <italic>Schistosoma mansoni </italic>eggs sensitization and challenge is regulated by LPA<sub>2</sub>.</p><fig id="F5" position="float"><label>Figure 5</label><caption><p><bold>LPA<sub>2</sub><sup>+/- </sup>mice exhibit a decrease in PGE2 and LPA levels in BAL fluids and COX-2 expression in lung tissue</bold>. BAL fluids and lung tissue were collected from SEA unchallenged and challenged wild type, LPA<sub>1</sub><sup>+/-</sup>, and LPA<sub>2</sub><sup>+/- </sup>mice (n = 4-6). <bold>A) </bold>PGE2 levels were measured by ELISA kit. <bold>B) </bold>Lung tissues were subjected to SDS/PAGE gel and COX-2 expression was determined by Western blotting. Representative image were shown. <bold>C) </bold>LPA levels in BAL fluids were quantified by LC-MS/MS and changes in LPA levels between wild type and SEA challenge mice were normalized to control levels.</p></caption><graphic xlink:href="1465-9921-10-114-5"/></fig></sec><sec><title>LPA<sub>2 </sub>deficiency on airway epithelial cells leads to reduced LPA mediated COX-2 expression and PGE2 release</title><p>Having demonstrated a role for LPA<sub>2 </sub>in <italic>Schistosoma. mansoni </italic>eggs-induced COX-2 expression, PGE2 secretion and airway inflammation, we hypothesized that expression of LPA<sub>2 </sub>on airway epithelial cells may be involved in inflammatory responses to <italic>Schistosoma. mansoni </italic>eggs sensitization and challenge. To investigate the role of LPA<sub>2 </sub>in LPA-induced COX-2 expression and PGE2 production, tracheal epithelial cells were isolated from wild type and LPA<sub>2</sub><sup>+/- </sup>mice. Analysis of total RNA for mRNA expression of LPA receptors by real-time RT-PCR revealed that expression of LPA<sub>2</sub>&#x0003e;LPA<sub>4</sub>&#x0003e;LPA<sub>1 </sub>&#x02265; LPA<sub>3 </sub>in mouse tracheal epithelial cells (Table <xref ref-type="table" rid="T3">3</xref>). In contrast to mouse tracheal epithelial cells, LPA<sub>1 </sub>and LPA<sub>3 </sub>were predominantly expressed in human bronchial epithelial cells [<xref ref-type="bibr" rid="B37">37</xref>]. In LPA<sub>2</sub><sup>+/- </sup>tracheal epithelial cells, expression of LPA<sub>2 </sub>mRNA was reduced to ~50%, compared to wild type mice, while there were no significant changes in expression levels of LPA<sub>1 </sub>and LPA<sub>3 </sub>mRNA (Fig. <xref ref-type="fig" rid="F6">6A</xref>). To determine the role of LPA<sub>2</sub>in LPA mediated COX-2 expression and PGE2 release, tracheal epithelial cells from wild type and LPA<sub>2</sub><sup>+/- </sup>mice were challenged with LPA (1 &#x003bc;M) for 3 h, total RNA isolated and COX-2 mRNA expression determined by Real-time RT-PCR. LPA stimulated COX-2 mRNA expression in wild type mouse cells (~13 fold); however, LPA-induced COX-2 mRNA expression was reduced in LPA<sub>2</sub><sup>+/- </sup>mouse cells (~56% of wild type cells) (Fig. <xref ref-type="fig" rid="F6">6B</xref>). The media, after LPA challenge, were collected and PGE2 levels were determined. As shown in Fig. <xref ref-type="fig" rid="F6">6C</xref>, PGE2 release from LPA<sub>2</sub><sup>+/-</sup>mouse tracheal epithelial cells challenged with LPA was lower as compared to cells from wild type mice [PGE2 (pg/ml)-Wild type: vehicle, 268 &#x000b1; 29; LPA, 432 &#x000b1; 47; LPA<sub>2</sub><sup>+/-</sup>: vehicle, 283 &#x000b1; 21; LPA, 374 &#x000b1; 16]. These results suggest that a role for LPA<sub>2 </sub>in LPA-induced COX-2 expression and PGE2 release from mouse tracheal epithelial cells.</p><fig id="F6" position="float"><label>Figure 6</label><caption><p><bold>LPA induces COX-2 expression and PGE2 release through LPA<sub>2</sub></bold>. Tracheal epithelial cells from wild type and LPA<sub>2</sub><sup>+/- </sup>mice were isolated as described in Materials and Methods and were cultured in 6-well plates. <bold>A) </bold>Total RNA was isolated and LPA receptors mRNA levels were measured by Real-time RT-PCR. <bold>B) </bold>Cells were challenged with 18:1LPA (1 &#x003bc;M) for 3 h, and COX-2 mRNA levels were measured by Real-time RT-PCR. <bold>(C)</bold>. Cells were challenged with 18:1LPA (1 &#x003bc;M) for 3 h, and medium were collected. PGE2 levels in medium were measured by ELISA kit.</p></caption><graphic xlink:href="1465-9921-10-114-6"/></fig><table-wrap id="T3" position="float"><label>Table 3</label><caption><p>LPA receptors mRNA expression in lung tissue</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">LPA-Rs</th><th align="center">LPA<sub>1</sub></th><th align="center">LPA<sub>2</sub></th><th align="center">LPA<sub>3</sub></th><th align="center">LPA<sub>4</sub></th><th align="center">LPA<sub>5</sub></th></tr></thead><tbody><tr><td align="left">Normalized to 18S</td><td align="center">49.5 &#x000b1; 23.5</td><td align="center">235.0 &#x000b1; 15.5</td><td align="center">46.0 &#x000b1; 21.2</td><td align="center">73.5 &#x000b1; 6.7</td><td align="center">n.d.</td></tr></tbody></table><table-wrap-foot><p>Total RNA were isolated from wild type mouse trachial epithelial cells and LPA receptors mRNA levels were determined by real-time RT-PCR with primers designed based on mouse LPA receptors mRNA sequence.</p></table-wrap-foot></table-wrap></sec></sec><sec><title>Discussion</title><p>In the present study, we present several novel findings regarding LPA receptors expression, and its role in infiltration of eosinophils and lung inflammation in <italic>Schistosoma mansoni </italic>eggs sensitized and challenged murine model of asthma. We provide direct evidence for increased LPA levels in BAL fluids from <italic>Schistosoma mansoni </italic>eggs sensitized and challenged mice compared to control mice and a direct link between LPA<sub>2</sub>expression and lung inflammation mediated by <italic>Schistosoma mansoni </italic>eggs sensitization and challenge. The pro-inflammatory role of LPA<sub>2 </sub>is also evident from reduced PGE2 levels in BAL fluids and COX-2 expression in lung tissues of LPA<sub>2</sub><sup>+/- </sup>mice sensitized and challenged with <italic>Schistosoma mansoni </italic>eggs compared to controls. We also demonstrate that airway epithelial cells isolated from LPA<sub>2</sub><sup>+/- </sup>mice, compared to cells from wild type mice, exhibited reduced COX-2 expression and PGE2 release in response to LPA. To the best of our knowledge, this is the first report demonstrating a functional link between LPA, LPA<sub>2 </sub>and lung inflammation in a murine model of asthma.</p><p>Asthma is a Th2-type immune disease of the lung that is characterized by chronic inflammation, infiltration of inflammatory cells, reversible obstruction of airway hyperresponsiveness, mucus hypersecretion by goblet cells and remodeling of the bronchoalveolar structures. Th1 and Th2 cytokines play a key role in orchestrating inflammatory and structural changes of the airway in asthma by recruiting, activating and promoting inflammatory cells into the airway [<xref ref-type="bibr" rid="B38">38</xref>-<xref ref-type="bibr" rid="B40">40</xref>]. In addition to cytokines, lipid mediators such as prostaglandins, leukotrienes, platelet-activating factor, and lysophospholipids regulate immune and inflammatory responses in asthma [<xref ref-type="bibr" rid="B41">41</xref>-<xref ref-type="bibr" rid="B43">43</xref>]. Many of these lipid mediators exert their biological responses via GPCRs. Increasing sphingosine-1-phosphate (S1P) levels in circulation offers protection against lung injury in mice and S1P-receptor 1 (S1P<sub>1</sub>) heterozygous mice showed enhanced inflammation after LPS challenge suggesting an anti-inflammatory role of S1P<sub>1 </sub>[<xref ref-type="bibr" rid="B44">44</xref>]. The present study demonstrates the role of LPA and LPA<sub>2</sub>, a GPCR, in the pathogenesis of allergic airway inflammation in <italic>Schistosoma mansoni </italic>eggs sensitized and challenged murine model of asthma. LPA<sub>1</sub><sup>-/- </sup>mice generated from LPA<sub>1</sub><sup>+/- </sup>colonies, as compared to LPA<sub>2</sub><sup>-/- </sup>from LPA<sub>2</sub><sup>+/-</sup>, showed 50% neonatal lethality and impaired suckling, and therefore, we decided to use LPA<sub>1</sub><sup>+/- </sup>and LPA<sub>2</sub><sup>+/- </sup>mice to investigate role of LPA receptors in airway inflammation. Although LPA<sub>1</sub><sup>+/- </sup>and LPA<sub>2</sub><sup>+/- </sup>mice exhibited less neutrophils infiltration, compared to wild type mice, after LPA challenge (Fig. <xref ref-type="fig" rid="F2">2</xref>), influx of eosinophils was lower in LPA<sub>2</sub><sup>+/-</sup>, but not in LPA<sub>1</sub><sup>+/- </sup>mice after <italic>Schistosoma mansoni </italic>eggs sensitization and challenge (Fig. <xref ref-type="fig" rid="F3">3B</xref>). Both LPA<sub>1</sub><sup>+/- </sup>and LPA<sub>2</sub><sup>+/- </sup>mice showed reduced PAS positive cells in the bronchus compared to wild type after <italic>Schistosoma mansoni </italic>eggs sensitization and challenge (Fig. <xref ref-type="fig" rid="F4">4</xref>) suggesting the potential involvement of LPA<sub>1 </sub>and LPA<sub>2 </sub>in activation of goblet cells. These results indicate that activation of goblet cells are dependent on LPA<sub>1 </sub>and LPA<sub>2</sub>, however, only LPA<sub>2 </sub>is involved in chemotaxis of eosinophils into alveolar space after <italic>Schistosoma mansoni </italic>eggs sensitization and challenge. Our current results on infiltration of eosinophils in <italic>Schistosoma mansoni </italic>eggs sensitized and challenged murine model of asthma are in good agreement with increased numbers of eosiophils, a characteristic feature of human bronchial asthma, in biopsies of human lung tissues [<xref ref-type="bibr" rid="B40">40</xref>,<xref ref-type="bibr" rid="B45">45</xref>]. LPA is constitutively present in human BAL fluids and increased following allergic inflammation [<xref ref-type="bibr" rid="B28">28</xref>] and in patients with pulmonary fibrosis [<xref ref-type="bibr" rid="B29">29</xref>]. Intratracheal administration of LPA increased eosinophil influx in guinea pigs [<xref ref-type="bibr" rid="B22">22</xref>] and treatment of human eosinophils with LPA induced calcium mobilization, actin reorganization, and chemotaxis through G&#x003b1;i-dependent LPA receptors [<xref ref-type="bibr" rid="B46">46</xref>]. In the present study, we found that LPA levels were increased by ~3 fold following <italic>Schistosoma mansoni </italic>eggs sensitization and challenge of wild type, which supports the notion of LPA as a chemotaxis factor of inflammatory cells in allergic inflammation.</p><p>The source of LPA accumulation and mechanism(s) of LPA generation in the lung after allergic inflammation is unclear. Our previous studies have demonstrated that acyl glycerol kinase (AGK) converts monoacylglycerol to LPA in human bronchial epithelial cells [<xref ref-type="bibr" rid="B47">47</xref>]. Further, phospholipase D (PLD) can also contribute to intracellular LPA generation by providing phosphatidic acid, a substrate for PA specific phospholipase A2 [<xref ref-type="bibr" rid="B48">48</xref>,<xref ref-type="bibr" rid="B49">49</xref>]. Interestingly, we observed that LPA levels in LPA<sub>2</sub><sup>+/- </sup>mice were significantly lower compared to wild type mice after <italic>Schistosoma mansoni </italic>eggs sensitization and challenge suggesting involvement of LPA<sub>2</sub> and potentially other LPA receptors in regulation of LPA generation in the airway. The relative contributions of AGK and/or PLD pathways in LPA generation in response to <italic>Schistosoma mansoni </italic>eggs sensitization and challenge are unknown Additionally, extracellular LPA can be generated by lysoPLD (autotaxin), which converts lysophosphatidylcholine (LPC) to LPA [<xref ref-type="bibr" rid="B50">50</xref>]. Not only LPC levels were increased in BAL fluids of segmental allergen challenged patients [<xref ref-type="bibr" rid="B51">51</xref>], there was an increase in lysoPLD expression in LPS-stimulated monocytes [<xref ref-type="bibr" rid="B52">52</xref>], and stimulation of lysoPLD activity in asthmatic patients [<xref ref-type="bibr" rid="B53">53</xref>]. Thus, increase in LPC levels and lysoPLD expression and activity may be involved in enhanced LPA generation during lung inflammation. Further studies are needed to establish the potential source(s) of LPA in BAL fluids and mechanism(s) of LPA generation during allergic lung inflammation.</p><p>In contrast to LPA, there are only a few reports that describe the role of LPA receptors in lung inflammation, injury and remodeling. Deletion of LPA<sub>1 </sub>reduced fibroblast recruitment and vascular leak in the bleomycin model of pulmonary fibrosis [<xref ref-type="bibr" rid="B29">29</xref>] while LPA/LPA<sub>2 </sub>signaling via &#x003b1;v&#x003b2;6 integrin-mediated activation of TGF-&#x003b2; has been implicated in the development of bleomycin-induced lung fibrosis in mice [<xref ref-type="bibr" rid="B54">54</xref>]. Down-regulation of LPA<sub>2 </sub>by siRNA attenuated LPA-induced phosphorylation of p38 MAPK/JNK, and IL-8 secretion in human bronchial epithelial cells [<xref ref-type="bibr" rid="B37">37</xref>]. Interestingly, <italic>Schistosoma mansoni </italic>eggs sensitization and challenge induced COX-2 expression and PGE2 was significantly attenuated in LPA<sub>2</sub><sup>+/-</sup>, but not LPA<sub>1</sub><sup>+/-</sup>, mice suggesting a potential link between reduced LPA<sub>2 </sub>expression and COX2/PGE2 levels. In accordance with our <italic>in vivo </italic>results on <italic>Schistosoma mansoni </italic>eggs mediated COX-2 expression and PGE2 release in mouse lungs, tracheal epithelial cells from LPA<sub>2</sub><sup>+/- </sup>mice exhibited decreased COX-2 expression and PGE2 release in response to LPA as compared to cells from wild type mice. Further, our results with LPA<sub>2</sub><sup>+/- </sup>mice suggest a role for LPA<sub>2 </sub>in the influx of eosinophils and lung inflammation induced by <italic>Schistosoma mansoni </italic>eggs sensitization and challenge suggest a role for LPA signaling via LPA<sub>2 </sub>in pro-inflammatory responses.</p></sec><sec><title>Conclusion</title><p>The present study demonstrates increased LPA levels in BAL fluids in a murine model of asthma and LPA<sub>2 </sub>heterozygous knockout mice show reduced Th-2 dominant airway inflammatory responses. These results suggest that endogenous LPA and LPA<sub>2 </sub>play a critical role in pathogenesis of airway inflammatory diseases. Therapeutic targeting of LPA<sub>2 </sub>may be beneficial in reducing allergic inflammatory responses in airway diseases.</p></sec><sec><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><sec><title>Authors' contributions</title><p>The study was designed and the protocol developed by YZ, JT, AIS, and VN. DH and SP carried out the genotyping. BE carried out the LPA measurement. JC provided the LPA<sub>1 </sub>and LPA<sub>2 </sub>heterozygous mice. All the authors read and approved the final manuscript.</p></sec></body><back><sec><title>Acknowledgements</title><p>The work was supported by National Institutes of Health grant HL091916 (to Y.Z.), HL71152 and HL79396 (to V.N.), MH51699 (to J.C.), and AI50180 (to A.I.S.)</p></sec><ref-list><ref id="B1"><mixed-citation publication-type="journal"><name><surname>Aoki</surname><given-names>J</given-names></name><name><surname>Taira</surname><given-names>A</given-names></name><name><surname>Takanezawa</surname><given-names>Y</given-names></name><name><surname>Kishi</surname><given-names>Y</given-names></name><name><surname>Hama</surname><given-names>K</given-names></name><name><surname>Kishimoto</surname><given-names>T</given-names></name><name><surname>Mizuno</surname><given-names>K</given-names></name><name><surname>Saku</surname><given-names>K</given-names></name><name><surname>Taguchi</surname><given-names>R</given-names></name><name><surname>Arai</surname><given-names>H</given-names></name><article-title>Serum lysophosphatidic acid is produced through diverse phospholipase pathways</article-title><source>The Journal of biological chemistry</source><year>2002</year><volume>277</volume><issue>50</issue><fpage>48737</fpage><lpage>48744</lpage><pub-id pub-id-type="doi">10.1074/jbc.M206812200</pub-id><pub-id pub-id-type="pmid">12354767</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><name><surname>Postma</surname><given-names>FR</given-names></name><name><surname>Jalink</surname><given-names>K</given-names></name><name><surname>Hengeveld</surname><given-names>T</given-names></name><name><surname>Bot</surname><given-names>AG</given-names></name><name><surname>Alblas</surname><given-names>J</given-names></name><name><surname>de Jonge</surname><given-names>HR</given-names></name><name><surname>Moolenaar</surname><given-names>WH</given-names></name><article-title>Serum-induced membrane depolarization in quiescent fibroblasts: activation of a chloride conductance through the G protein-coupled LPA receptor</article-title><source>The EMBO journal</source><year>1996</year><volume>15</volume><issue>1</issue><fpage>63</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">8598207</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><name><surname>Tigyi</surname><given-names>G</given-names></name><name><surname>Miledi</surname><given-names>R</given-names></name><article-title>Lysophosphatidates bound to serum albumin activate membrane currents in Xenopus oocytes and neurite retraction in PC12 pheochromocytoma cells</article-title><source>The Journal of biological chemistry</source><year>1992</year><volume>267</volume><issue>30</issue><fpage>21360</fpage><lpage>21367</lpage><pub-id pub-id-type="pmid">1383223</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><name><surname>Mills</surname><given-names>GB</given-names></name><name><surname>Moolenaar</surname><given-names>WH</given-names></name><article-title>The emerging role of lysophosphatidic acid in cancer</article-title><source>Nature reviews</source><year>2003</year><volume>3</volume><issue>8</issue><fpage>582</fpage><lpage>591</lpage><pub-id pub-id-type="doi">10.1038/nrc1143</pub-id><pub-id pub-id-type="pmid">12894246</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><name><surname>van Corven</surname><given-names>EJ</given-names></name><name><surname>Groenink</surname><given-names>A</given-names></name><name><surname>Jalink</surname><given-names>K</given-names></name><name><surname>Eichholtz</surname><given-names>T</given-names></name><name><surname>Moolenaar</surname><given-names>WH</given-names></name><article-title>Lysophosphatidate-induced cell proliferation: identification and dissection of signaling pathways mediated by G proteins</article-title><source>Cell</source><year>1989</year><volume>59</volume><issue>1</issue><fpage>45</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1016/0092-8674(89)90868-4</pub-id><pub-id pub-id-type="pmid">2551506</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal"><name><surname>Hao</surname><given-names>F</given-names></name><name><surname>Tan</surname><given-names>M</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Han</surname><given-names>J</given-names></name><name><surname>Miller</surname><given-names>DD</given-names></name><name><surname>Tigyi</surname><given-names>G</given-names></name><name><surname>Cui</surname><given-names>MZ</given-names></name><article-title>Lysophosphatidic acid induces prostate cancer PC3 cell migration via activation of LPA(1), p42 and p38alpha</article-title><source>Biochimica et biophysica acta</source><year>2007</year><volume>1771</volume><issue>7</issue><fpage>883</fpage><lpage>892</lpage><pub-id pub-id-type="pmid">17531530</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal"><name><surname>van Leeuwen</surname><given-names>FN</given-names></name><name><surname>Giepmans</surname><given-names>BN</given-names></name><name><surname>van Meeteren</surname><given-names>LA</given-names></name><name><surname>Moolenaar</surname><given-names>WH</given-names></name><article-title>Lysophosphatidic acid: mitogen and motility factor</article-title><source>Biochemical Society transactions</source><year>2003</year><volume>31</volume><issue>Pt 6</issue><fpage>1209</fpage><lpage>1212</lpage><pub-id pub-id-type="doi">10.1042/BST0311209</pub-id><pub-id pub-id-type="pmid">14641027</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>He</surname><given-names>D</given-names></name><name><surname>Saatian</surname><given-names>B</given-names></name><name><surname>Watkins</surname><given-names>T</given-names></name><name><surname>Spannhake</surname><given-names>EW</given-names></name><name><surname>Pyne</surname><given-names>NJ</given-names></name><name><surname>Natarajan</surname><given-names>V</given-names></name><article-title>Regulation of lysophosphatidic acid-induced epidermal growth factor receptor transactivation and interleukin-8 secretion in human bronchial epithelial cells by protein kinase Cdelta, Lyn kinase, and matrix metalloproteinases</article-title><source>The Journal of biological chemistry</source><year>2006</year><volume>281</volume><issue>28</issue><fpage>19501</fpage><lpage>19511</lpage><pub-id pub-id-type="doi">10.1074/jbc.M511224200</pub-id><pub-id pub-id-type="pmid">16687414</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>He</surname><given-names>D</given-names></name><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Leff</surname><given-names>AR</given-names></name><name><surname>Spannhake</surname><given-names>EW</given-names></name><name><surname>Georas</surname><given-names>S</given-names></name><name><surname>Natarajan</surname><given-names>V</given-names></name><article-title>Lysophosphatidic acid induces interleukin-13 (IL-13) receptor alpha2 expression and inhibits IL-13 signaling in primary human bronchial epithelial cells</article-title><source>The Journal of biological chemistry</source><year>2007</year><volume>282</volume><issue>14</issue><fpage>10172</fpage><lpage>10179</lpage><pub-id pub-id-type="doi">10.1074/jbc.M611210200</pub-id><pub-id pub-id-type="pmid">17287216</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Usatyuk</surname><given-names>PV</given-names></name><name><surname>Cummings</surname><given-names>R</given-names></name><name><surname>Saatian</surname><given-names>B</given-names></name><name><surname>He</surname><given-names>D</given-names></name><name><surname>Watkins</surname><given-names>T</given-names></name><name><surname>Morris</surname><given-names>A</given-names></name><name><surname>Spannhake</surname><given-names>EW</given-names></name><name><surname>Brindley</surname><given-names>DN</given-names></name><name><surname>Natarajan</surname><given-names>V</given-names></name><article-title>Lipid phosphate phosphatase-1 regulates lysophosphatidic acid-induced calcium release, NF-kappaB activation and interleukin-8 secretion in human bronchial epithelial cells</article-title><source>The Biochemical journal</source><year>2005</year><volume>385</volume><issue>Pt 2</issue><fpage>493</fpage><lpage>502</lpage><pub-id pub-id-type="pmid">15461590</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><name><surname>An</surname><given-names>S</given-names></name><name><surname>Dickens</surname><given-names>MA</given-names></name><name><surname>Bleu</surname><given-names>T</given-names></name><name><surname>Hallmark</surname><given-names>OG</given-names></name><name><surname>Goetzl</surname><given-names>EJ</given-names></name><article-title>Molecular cloning of the human Edg2 protein and its identification as a functional cellular receptor for lysophosphatidic acid</article-title><source>Biochemical and biophysical research communications</source><year>1997</year><volume>231</volume><issue>3</issue><fpage>619</fpage><lpage>622</lpage><pub-id pub-id-type="doi">10.1006/bbrc.1997.6150</pub-id><pub-id pub-id-type="pmid">9070858</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><name><surname>Chun</surname><given-names>J</given-names></name><article-title>Lysophospholipid receptors: implications for neural signaling</article-title><source>Critical reviews in neurobiology</source><year>1999</year><volume>13</volume><issue>2</issue><fpage>151</fpage><lpage>168</lpage><pub-id pub-id-type="pmid">10512488</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><name><surname>Fukushima</surname><given-names>N</given-names></name><name><surname>Kimura</surname><given-names>Y</given-names></name><name><surname>Chun</surname><given-names>J</given-names></name><article-title>A single receptor encoded by vzg-1/lpA1/edg-2 couples to G proteins and mediates multiple cellular responses to lysophosphatidic acid</article-title><source>Proceedings of the National Academy of Sciences of the United States of America</source><year>1998</year><volume>95</volume><issue>11</issue><fpage>6151</fpage><lpage>6156</lpage><pub-id pub-id-type="doi">10.1073/pnas.95.11.6151</pub-id><pub-id pub-id-type="pmid">9600933</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><name><surname>Im</surname><given-names>DS</given-names></name><name><surname>Heise</surname><given-names>CE</given-names></name><name><surname>Harding</surname><given-names>MA</given-names></name><name><surname>George</surname><given-names>SR</given-names></name><name><surname>O'Dowd</surname><given-names>BF</given-names></name><name><surname>Theodorescu</surname><given-names>D</given-names></name><name><surname>Lynch</surname><given-names>KR</given-names></name><article-title>Molecular cloning and characterization of a lysophosphatidic acid receptor, Edg-7, expressed in prostate</article-title><source>Molecular pharmacology</source><year>2000</year><volume>57</volume><issue>4</issue><fpage>753</fpage><lpage>759</lpage><pub-id pub-id-type="pmid">10727522</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><name><surname>Lee</surname><given-names>CW</given-names></name><name><surname>Rivera</surname><given-names>R</given-names></name><name><surname>Gardell</surname><given-names>S</given-names></name><name><surname>Dubin</surname><given-names>AE</given-names></name><name><surname>Chun</surname><given-names>J</given-names></name><article-title>GPR92 as a new G12/13- and Gq-coupled lysophosphatidic acid receptor that increases cAMP, LPA5</article-title><source>The Journal of biological chemistry</source><year>2006</year><volume>281</volume><issue>33</issue><fpage>23589</fpage><lpage>23597</lpage><pub-id pub-id-type="doi">10.1074/jbc.M603670200</pub-id><pub-id pub-id-type="pmid">16774927</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><name><surname>Noguchi</surname><given-names>K</given-names></name><name><surname>Ishii</surname><given-names>S</given-names></name><name><surname>Shimizu</surname><given-names>T</given-names></name><article-title>Identification of p2y9/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family</article-title><source>The Journal of biological chemistry</source><year>2003</year><volume>278</volume><issue>28</issue><fpage>25600</fpage><lpage>25606</lpage><pub-id pub-id-type="doi">10.1074/jbc.M302648200</pub-id><pub-id pub-id-type="pmid">12724320</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><name><surname>Tabata</surname><given-names>K</given-names></name><name><surname>Baba</surname><given-names>K</given-names></name><name><surname>Shiraishi</surname><given-names>A</given-names></name><name><surname>Ito</surname><given-names>M</given-names></name><name><surname>Fujita</surname><given-names>N</given-names></name><article-title>The orphan GPCR GPR87 was deorphanized and shown to be a lysophosphatidic acid receptor</article-title><source>Biochemical and biophysical research communications</source><year>2007</year><volume>363</volume><issue>3</issue><fpage>861</fpage><lpage>866</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2007.09.063</pub-id><pub-id pub-id-type="pmid">17905198</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><name><surname>Cerutis</surname><given-names>DR</given-names></name><name><surname>Nogami</surname><given-names>M</given-names></name><name><surname>Anderson</surname><given-names>JL</given-names></name><name><surname>Churchill</surname><given-names>JD</given-names></name><name><surname>Romberger</surname><given-names>DJ</given-names></name><name><surname>Rennard</surname><given-names>SI</given-names></name><name><surname>Toews</surname><given-names>ML</given-names></name><article-title>Lysophosphatidic acid and EGF stimulate mitogenesis in human airway smooth muscle cells</article-title><source>The American journal of physiology</source><year>1997</year><volume>273</volume><issue>1 Pt 1</issue><fpage>L10</fpage><lpage>15</lpage><pub-id pub-id-type="pmid">9252534</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><name><surname>Toews</surname><given-names>ML</given-names></name><name><surname>Ustinova</surname><given-names>EE</given-names></name><name><surname>Schultz</surname><given-names>HD</given-names></name><article-title>Lysophosphatidic acid enhances contractility of isolated airway smooth muscle</article-title><source>J Appl Physiol</source><year>1997</year><volume>83</volume><issue>4</issue><fpage>1216</fpage><lpage>1222</lpage><pub-id pub-id-type="pmid">9338431</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><name><surname>Cummings</surname><given-names>R</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Jacoby</surname><given-names>D</given-names></name><name><surname>Spannhake</surname><given-names>EW</given-names></name><name><surname>Ohba</surname><given-names>M</given-names></name><name><surname>Garcia</surname><given-names>JG</given-names></name><name><surname>Watkins</surname><given-names>T</given-names></name><name><surname>He</surname><given-names>D</given-names></name><name><surname>Saatian</surname><given-names>B</given-names></name><name><surname>Natarajan</surname><given-names>V</given-names></name><article-title>Protein kinase Cdelta mediates lysophosphatidic acid-induced NF-kappaB activation and interleukin-8 secretion in human bronchial epithelial cells</article-title><source>The Journal of biological chemistry</source><year>2004</year><volume>279</volume><issue>39</issue><fpage>41085</fpage><lpage>41094</lpage><pub-id pub-id-type="doi">10.1074/jbc.M404045200</pub-id><pub-id pub-id-type="pmid">15280372</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><name><surname>Hashimoto</surname><given-names>T</given-names></name><name><surname>Nakano</surname><given-names>Y</given-names></name><name><surname>Yamashita</surname><given-names>M</given-names></name><name><surname>Fang</surname><given-names>YI</given-names></name><name><surname>Ohata</surname><given-names>H</given-names></name><name><surname>Momose</surname><given-names>K</given-names></name><article-title>Role of Rho-associated protein kinase and histamine in lysophosphatidic acid-induced airway hyperresponsiveness in guinea pigs</article-title><source>Japanese journal of pharmacology</source><year>2002</year><volume>88</volume><issue>3</issue><fpage>256</fpage><lpage>261</lpage><pub-id pub-id-type="doi">10.1254/jjp.88.256</pub-id><pub-id pub-id-type="pmid">11949879</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><name><surname>Hashimoto</surname><given-names>T</given-names></name><name><surname>Yamashita</surname><given-names>M</given-names></name><name><surname>Ohata</surname><given-names>H</given-names></name><name><surname>Momose</surname><given-names>K</given-names></name><article-title>Lysophosphatidic acid enhances in vivo infiltration and activation of guinea pig eosinophils and neutrophils via a Rho/Rho-associated protein kinase-mediated pathway</article-title><source>Journal of pharmacological sciences</source><year>2003</year><volume>91</volume><issue>1</issue><fpage>8</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1254/jphs.91.8</pub-id><pub-id pub-id-type="pmid">12686725</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><name><surname>He</surname><given-names>D</given-names></name><name><surname>Natarajan</surname><given-names>V</given-names></name><name><surname>Stern</surname><given-names>R</given-names></name><name><surname>Gorshkova</surname><given-names>IA</given-names></name><name><surname>Solway</surname><given-names>J</given-names></name><name><surname>Spannhake</surname><given-names>EW</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><article-title>Lysophosphatidic acid-induced transactivation of epidermal growth factor receptor regulates cyclo-oxygenase-2 expression and prostaglandin E(2) release via C/EBPbeta in human bronchial epithelial cells</article-title><source>The Biochemical journal</source><year>2008</year><volume>412</volume><issue>1</issue><fpage>153</fpage><lpage>162</lpage><pub-id pub-id-type="doi">10.1042/BJ20071649</pub-id><pub-id pub-id-type="pmid">18294142</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><name><surname>Oguma</surname><given-names>T</given-names></name><name><surname>Asano</surname><given-names>K</given-names></name><name><surname>Shiomi</surname><given-names>T</given-names></name><name><surname>Fukunaga</surname><given-names>K</given-names></name><name><surname>Suzuki</surname><given-names>Y</given-names></name><name><surname>Nakamura</surname><given-names>M</given-names></name><name><surname>Matsubara</surname><given-names>H</given-names></name><name><surname>Sheldon</surname><given-names>HK</given-names></name><name><surname>Haley</surname><given-names>KJ</given-names></name><name><surname>Lilly</surname><given-names>CM</given-names></name><article-title>Cyclooxygenase-2 expression during allergic inflammation in guinea-pig lungs</article-title><source>American journal of respiratory and critical care medicine</source><year>2002</year><volume>165</volume><issue>3</issue><fpage>382</fpage><lpage>386</lpage><pub-id pub-id-type="pmid">11818325</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><name><surname>Vancheri</surname><given-names>C</given-names></name><name><surname>Mastruzzo</surname><given-names>C</given-names></name><name><surname>Sortino</surname><given-names>MA</given-names></name><name><surname>Crimi</surname><given-names>N</given-names></name><article-title>The lung as a privileged site for the beneficial actions of PGE2</article-title><source>Trends in immunology</source><year>2004</year><volume>25</volume><issue>1</issue><fpage>40</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1016/j.it.2003.11.001</pub-id><pub-id pub-id-type="pmid">14698283</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><name><surname>Fan</surname><given-names>H</given-names></name><name><surname>Zingarelli</surname><given-names>B</given-names></name><name><surname>Harris</surname><given-names>V</given-names></name><name><surname>Tempel</surname><given-names>GE</given-names></name><name><surname>Halushka</surname><given-names>PV</given-names></name><name><surname>Cook</surname><given-names>JA</given-names></name><article-title>Lysophosphatidic acid inhibits bacterial endotoxin-induced pro-inflammatory response: potential anti-inflammatory signaling pathways</article-title><source>Molecular medicine (Cambridge, Mass)</source><year>2008</year><volume>14</volume><issue>7-8</issue><fpage>422</fpage><lpage>428</lpage><pub-id pub-id-type="pmid">18431464</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><name><surname>He</surname><given-names>D</given-names></name><name><surname>Su</surname><given-names>Y</given-names></name><name><surname>Usatyuk</surname><given-names>PV</given-names></name><name><surname>Spannhake</surname><given-names>EW</given-names></name><name><surname>Kogut</surname><given-names>P</given-names></name><name><surname>Solway</surname><given-names>J</given-names></name><name><surname>Natarajan</surname><given-names>V</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><article-title>Lysophosphatidic Acid Enhances Pulmonary Epithelial Barrier Integrity and Protects Endotoxin-induced Epithelial Barrier Disruption and Lung Injury</article-title><source>The Journal of biological chemistry</source><year>2009</year><volume>284</volume><issue>36</issue><fpage>24123</fpage><lpage>24132</lpage><pub-id pub-id-type="doi">10.1074/jbc.M109.007393</pub-id><pub-id pub-id-type="pmid">19586906</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><name><surname>Georas</surname><given-names>SN</given-names></name><name><surname>Berdyshev</surname><given-names>E</given-names></name><name><surname>Hubbard</surname><given-names>W</given-names></name><name><surname>Gorshkova</surname><given-names>IA</given-names></name><name><surname>Usatyuk</surname><given-names>PV</given-names></name><name><surname>Saatian</surname><given-names>B</given-names></name><name><surname>Myers</surname><given-names>AC</given-names></name><name><surname>Williams</surname><given-names>MA</given-names></name><name><surname>Xiao</surname><given-names>HQ</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><article-title>Lysophosphatidic acid is detectable in human bronchoalveolar lavage fluids at baseline and increased after segmental allergen challenge</article-title><source>Clin Exp Allergy</source><year>2007</year><volume>37</volume><issue>3</issue><fpage>311</fpage><lpage>322</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2222.2006.02626.x</pub-id><pub-id pub-id-type="pmid">17359381</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><name><surname>Tager</surname><given-names>AM</given-names></name><name><surname>LaCamera</surname><given-names>P</given-names></name><name><surname>Shea</surname><given-names>BS</given-names></name><name><surname>Campanella</surname><given-names>GS</given-names></name><name><surname>Selman</surname><given-names>M</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name><name><surname>Polosukhin</surname><given-names>V</given-names></name><name><surname>Wain</surname><given-names>J</given-names></name><name><surname>Karimi-Shah</surname><given-names>BA</given-names></name><name><surname>Kim</surname><given-names>ND</given-names></name><article-title>The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak</article-title><source>Nature medicine</source><year>2008</year><volume>14</volume><issue>1</issue><fpage>45</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1038/nm1685</pub-id><pub-id pub-id-type="pmid">18066075</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><name><surname>Cannon</surname><given-names>JL</given-names></name><name><surname>Collins</surname><given-names>A</given-names></name><name><surname>Mody</surname><given-names>PD</given-names></name><name><surname>Balachandran</surname><given-names>D</given-names></name><name><surname>Henriksen</surname><given-names>KJ</given-names></name><name><surname>Smith</surname><given-names>CE</given-names></name><name><surname>Tong</surname><given-names>J</given-names></name><name><surname>Clay</surname><given-names>BS</given-names></name><name><surname>Miller</surname><given-names>SD</given-names></name><name><surname>Sperling</surname><given-names>AI</given-names></name><article-title>CD43 regulates Th2 differentiation and inflammation</article-title><source>J Immunol</source><year>2008</year><volume>180</volume><issue>11</issue><fpage>7385</fpage><lpage>7393</lpage><pub-id pub-id-type="pmid">18490738</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><name><surname>Padrid</surname><given-names>PA</given-names></name><name><surname>Mathur</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Herrmann</surname><given-names>K</given-names></name><name><surname>Qin</surname><given-names>Y</given-names></name><name><surname>Cattamanchi</surname><given-names>A</given-names></name><name><surname>Weinstock</surname><given-names>J</given-names></name><name><surname>Elliott</surname><given-names>D</given-names></name><name><surname>Sperling</surname><given-names>AI</given-names></name><name><surname>Bluestone</surname><given-names>JA</given-names></name><article-title>CTLA4Ig inhibits airway eosinophilia and hyperresponsiveness by regulating the development of Th1/Th2 subsets in a murine model of asthma</article-title><source>American journal of respiratory cell and molecular biology</source><year>1998</year><volume>18</volume><issue>4</issue><fpage>453</fpage><lpage>462</lpage><pub-id pub-id-type="pmid">9533932</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><name><surname>Tong</surname><given-names>J</given-names></name><name><surname>Bandulwala</surname><given-names>HS</given-names></name><name><surname>Clay</surname><given-names>BS</given-names></name><name><surname>Anders</surname><given-names>RA</given-names></name><name><surname>Shilling</surname><given-names>RA</given-names></name><name><surname>Balachandran</surname><given-names>DD</given-names></name><name><surname>Chen</surname><given-names>B</given-names></name><name><surname>Weinstock</surname><given-names>JV</given-names></name><name><surname>Solway</surname><given-names>J</given-names></name><name><surname>Hamann</surname><given-names>KJ</given-names></name><article-title>Fas-positive T cells regulate the resolution of airway inflammation in a murine model of asthma</article-title><source>The Journal of experimental medicine</source><year>2006</year><volume>203</volume><issue>5</issue><fpage>1173</fpage><lpage>1184</lpage><pub-id pub-id-type="doi">10.1084/jem.20051680</pub-id><pub-id pub-id-type="pmid">16618792</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><name><surname>Contos</surname><given-names>JJ</given-names></name><name><surname>Fukushima</surname><given-names>N</given-names></name><name><surname>Weiner</surname><given-names>JA</given-names></name><name><surname>Kaushal</surname><given-names>D</given-names></name><name><surname>Chun</surname><given-names>J</given-names></name><article-title>Requirement for the lpA1 lysophosphatidic acid receptor gene in normal suckling behavior</article-title><source>Proceedings of the National Academy of Sciences of the United States of America</source><year>2000</year><volume>97</volume><issue>24</issue><fpage>13384</fpage><lpage>13389</lpage><pub-id pub-id-type="doi">10.1073/pnas.97.24.13384</pub-id><pub-id pub-id-type="pmid">11087877</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><name><surname>Contos</surname><given-names>JJ</given-names></name><name><surname>Ishii</surname><given-names>I</given-names></name><name><surname>Fukushima</surname><given-names>N</given-names></name><name><surname>Kingsbury</surname><given-names>MA</given-names></name><name><surname>Ye</surname><given-names>X</given-names></name><name><surname>Kawamura</surname><given-names>S</given-names></name><name><surname>Brown</surname><given-names>JH</given-names></name><name><surname>Chun</surname><given-names>J</given-names></name><article-title>Characterization of lpa(2) (Edg4) and lpa(1)/lpa(2) (Edg2/Edg4) lysophosphatidic acid receptor knockout mice: signaling deficits without obvious phenotypic abnormality attributable to lpa(2)</article-title><source>Molecular and cellular biology</source><year>2002</year><volume>22</volume><issue>19</issue><fpage>6921</fpage><lpage>6929</lpage><pub-id pub-id-type="doi">10.1128/MCB.22.19.6921-6929.2002</pub-id><pub-id pub-id-type="pmid">12215548</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><name><surname>Newman</surname><given-names>JH</given-names></name><name><surname>Sheller</surname><given-names>JR</given-names></name><article-title>Arachidonic acid metabolites in the healthy and diseased lung</article-title><source>The American journal of the medical sciences</source><year>1984</year><volume>288</volume><issue>2</issue><fpage>75</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1097/00000441-198409000-00005</pub-id><pub-id pub-id-type="pmid">6091454</pub-id></mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal"><name><surname>Gauvreau</surname><given-names>GM</given-names></name><name><surname>Watson</surname><given-names>RM</given-names></name><name><surname>O'Byrne</surname><given-names>PM</given-names></name><article-title>Protective effects of inhaled PGE2 on allergen-induced airway responses and airway inflammation</article-title><source>American journal of respiratory and critical care medicine</source><year>1999</year><volume>159</volume><issue>1</issue><fpage>31</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">9872814</pub-id></mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal"><name><surname>Saatian</surname><given-names>B</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>He</surname><given-names>D</given-names></name><name><surname>Georas</surname><given-names>SN</given-names></name><name><surname>Watkins</surname><given-names>T</given-names></name><name><surname>Spannhake</surname><given-names>EW</given-names></name><name><surname>Natarajan</surname><given-names>V</given-names></name><article-title>Transcriptional regulation of lysophosphatidic acid-induced interleukin-8 expression and secretion by p38 MAPK and JNK in human bronchial epithelial cells</article-title><source>The Biochemical journal</source><year>2006</year><volume>393</volume><issue>Pt 3</issue><fpage>657</fpage><lpage>668</lpage><pub-id pub-id-type="pmid">16197369</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal"><name><surname>Averbeck</surname><given-names>M</given-names></name><name><surname>Gebhardt</surname><given-names>C</given-names></name><name><surname>Emmrich</surname><given-names>F</given-names></name><name><surname>Treudler</surname><given-names>R</given-names></name><name><surname>Simon</surname><given-names>JC</given-names></name><article-title>Immunologic principles of allergic disease</article-title><source>J Dtsch Dermatol Ges</source><year>2007</year><volume>5</volume><issue>11</issue><fpage>1015</fpage><lpage>1028</lpage><pub-id pub-id-type="doi">10.1111/j.1610-0387.2007.06538.x</pub-id><pub-id pub-id-type="pmid">17976144</pub-id></mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal"><name><surname>Doherty</surname><given-names>T</given-names></name><name><surname>Broide</surname><given-names>D</given-names></name><article-title>Cytokines and growth factors in airway remodeling in asthma</article-title><source>Current opinion in immunology</source><year>2007</year><volume>19</volume><issue>6</issue><fpage>676</fpage><lpage>680</lpage><pub-id pub-id-type="doi">10.1016/j.coi.2007.07.017</pub-id><pub-id pub-id-type="pmid">17720466</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal"><name><surname>Elsas</surname><given-names>PX</given-names></name><name><surname>Elsas</surname><given-names>MI</given-names></name><article-title>Eosinophilopoiesis at the cross-roads of research on development, immunity and drug discovery</article-title><source>Current medicinal chemistry</source><year>2007</year><volume>14</volume><issue>18</issue><fpage>1925</fpage><lpage>1939</lpage><pub-id pub-id-type="doi">10.2174/092986707781368487</pub-id><pub-id pub-id-type="pmid">17691935</pub-id></mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal"><name><surname>Bonnans</surname><given-names>C</given-names></name><name><surname>Levy</surname><given-names>BD</given-names></name><article-title>Lipid mediators as agonists for the resolution of acute lung inflammation and injury</article-title><source>American journal of respiratory cell and molecular biology</source><year>2007</year><volume>36</volume><issue>2</issue><fpage>201</fpage><lpage>205</lpage><pub-id pub-id-type="doi">10.1165/rcmb.2006-0269TR</pub-id><pub-id pub-id-type="pmid">16990613</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal"><name><surname>Peters-Golden</surname><given-names>M</given-names></name><name><surname>Canetti</surname><given-names>C</given-names></name><name><surname>Mancuso</surname><given-names>P</given-names></name><name><surname>Coffey</surname><given-names>MJ</given-names></name><article-title>Leukotrienes: underappreciated mediators of innate immune responses</article-title><source>J Immunol</source><year>2005</year><volume>174</volume><issue>2</issue><fpage>589</fpage><lpage>594</lpage><pub-id pub-id-type="pmid">15634873</pub-id></mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal"><name><surname>Ryan</surname><given-names>JJ</given-names></name><name><surname>Spiegel</surname><given-names>S</given-names></name><article-title>The role of sphingosine-1-phosphate and its receptors in asthma</article-title><source>Drug news &#x00026; perspectives</source><year>2008</year><volume>21</volume><issue>2</issue><fpage>89</fpage><lpage>96</lpage><pub-id pub-id-type="pmid">18389100</pub-id><pub-id pub-id-type="doi">10.1358/dnp.2008.21.2.1188195</pub-id></mixed-citation></ref><ref id="B44"><mixed-citation publication-type="other"><name><surname>Sammi</surname><given-names>S</given-names></name><name><surname>Vinasco</surname><given-names>LM</given-names></name><name><surname>Mirzapoiazova</surname><given-names>T</given-names></name><name><surname>Singleton</surname><given-names>PA</given-names></name><name><surname>Chiang</surname><given-names>ET</given-names></name><name><surname>Evenoski</surname><given-names>CL</given-names></name><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Mathew</surname><given-names>B</given-names></name><name><surname>Husain</surname><given-names>A</given-names></name><name><surname>Moitra</surname><given-names>J</given-names></name><name><surname>Sun</surname><given-names>X</given-names></name><name><surname>Nenez</surname><given-names>L</given-names></name><name><surname>Jacobson</surname><given-names>JR</given-names></name><name><surname>Dudek</surname><given-names>S</given-names></name><name><surname>Natarajan</surname><given-names>V</given-names></name><name><surname>Garcia</surname><given-names>JGN</given-names></name><article-title>Differential Effects of S1P Receptors on Airway and Vascular Barrier Function in the Murine Lung</article-title><source>American journal of respiratory and critical care medicine</source><year>2009</year><comment> in press </comment></mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal"><name><surname>Lee</surname><given-names>SY</given-names></name><name><surname>Kim</surname><given-names>HB</given-names></name><name><surname>Kim</surname><given-names>JH</given-names></name><name><surname>Kim</surname><given-names>BS</given-names></name><name><surname>Kang</surname><given-names>MJ</given-names></name><name><surname>Jang</surname><given-names>SO</given-names></name><name><surname>Hong</surname><given-names>SJ</given-names></name><article-title>Eosinophils play a major role in the severity of exercise-induced bronchoconstriction in children with asthma</article-title><source>Pediatric pulmonology</source><year>2006</year><volume>41</volume><issue>12</issue><fpage>1161</fpage><lpage>1166</lpage><pub-id pub-id-type="doi">10.1002/ppul.20506</pub-id><pub-id pub-id-type="pmid">17048254</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal"><name><surname>Idzko</surname><given-names>M</given-names></name><name><surname>Laut</surname><given-names>M</given-names></name><name><surname>Panther</surname><given-names>E</given-names></name><name><surname>Sorichter</surname><given-names>S</given-names></name><name><surname>Durk</surname><given-names>T</given-names></name><name><surname>Fluhr</surname><given-names>JW</given-names></name><name><surname>Herouy</surname><given-names>Y</given-names></name><name><surname>Mockenhaupt</surname><given-names>M</given-names></name><name><surname>Myrtek</surname><given-names>D</given-names></name><name><surname>Elsner</surname><given-names>P</given-names></name><article-title>Lysophosphatidic acid induces chemotaxis, oxygen radical production, CD11b up-regulation, Ca2+ mobilization, and actin reorganization in human eosinophils via pertussis toxin-sensitive G proteins</article-title><source>J Immunol</source><year>2004</year><volume>172</volume><issue>7</issue><fpage>4480</fpage><lpage>4485</lpage><pub-id pub-id-type="pmid">15034064</pub-id></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal"><name><surname>Kalari</surname><given-names>S</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Berdyshev</surname><given-names>E</given-names></name><name><surname>Usatyuk</surname><given-names>PV</given-names></name><name><surname>He</surname><given-names>D</given-names></name><name><surname>Natarajan</surname><given-names>V</given-names></name><article-title>Role of acylglycerol kinase in lysophosphatidic acid-induced transactivation of epidermal growth factor receptor and expression of cyclooxygenase 2 and inerluikin-8 in primary human bronchial epithelial cells</article-title><source>J Invest Medicine</source><year>2007</year><volume>55</volume><issue>2</issue><fpage>S356</fpage></mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal"><name><surname>Aoki</surname><given-names>J</given-names></name><article-title>Mechanisms of lysophosphatidic acid production</article-title><source>Seminars in cell &#x00026; developmental biology</source><year>2004</year><volume>15</volume><issue>5</issue><fpage>477</fpage><lpage>489</lpage><pub-id pub-id-type="doi">10.1016/j.semcdb.2004.05.001</pub-id><pub-id pub-id-type="pmid">15271293</pub-id></mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal"><name><surname>Sano</surname><given-names>T</given-names></name><name><surname>Baker</surname><given-names>D</given-names></name><name><surname>Virag</surname><given-names>T</given-names></name><name><surname>Wada</surname><given-names>A</given-names></name><name><surname>Yatomi</surname><given-names>Y</given-names></name><name><surname>Kobayashi</surname><given-names>T</given-names></name><name><surname>Igarashi</surname><given-names>Y</given-names></name><name><surname>Tigyi</surname><given-names>G</given-names></name><article-title>Multiple mechanisms linked to platelet activation result in lysophosphatidic acid and sphingosine 1-phosphate generation in blood</article-title><source>The Journal of biological chemistry</source><year>2002</year><volume>277</volume><issue>24</issue><fpage>21197</fpage><lpage>21206</lpage><pub-id pub-id-type="doi">10.1074/jbc.M201289200</pub-id><pub-id pub-id-type="pmid">11929870</pub-id></mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal"><name><surname>Morris</surname><given-names>AJ</given-names></name><name><surname>Smyth</surname><given-names>SS</given-names></name><article-title>Measurement of autotaxin/lysophospholipase D activity</article-title><source>Methods in enzymology</source><year>2007</year><volume>434</volume><fpage>89</fpage><lpage>104</lpage><comment>full_text</comment><pub-id pub-id-type="pmid">17954243</pub-id></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal"><name><surname>Chilton</surname><given-names>FH</given-names></name><name><surname>Averill</surname><given-names>FJ</given-names></name><name><surname>Hubbard</surname><given-names>WC</given-names></name><name><surname>Fonteh</surname><given-names>AN</given-names></name><name><surname>Triggiani</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>MC</given-names></name><article-title>Antigen-induced generation of lyso-phospholipids in human airways</article-title><source>The Journal of experimental medicine</source><year>1996</year><volume>183</volume><issue>5</issue><fpage>2235</fpage><lpage>2245</lpage><pub-id pub-id-type="doi">10.1084/jem.183.5.2235</pub-id><pub-id pub-id-type="pmid">8642333</pub-id></mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><article-title>Lipopolysaccharide induces autotaxin expression in human monocytic THP-1 cells</article-title><source>Biochemical and biophysical research communications</source><year>2009</year><volume>378</volume><issue>2</issue><fpage>264</fpage><lpage>268</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2008.11.047</pub-id><pub-id pub-id-type="pmid">19027716</pub-id></mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal"><name><surname>Duff</surname><given-names>RF</given-names></name><name><surname>Emo</surname><given-names>J</given-names></name><name><surname>Friedman</surname><given-names>A</given-names></name><name><surname>Larj</surname><given-names>M</given-names></name><name><surname>Lyda</surname><given-names>E</given-names></name><name><surname>O'Loughlin</surname><given-names>C</given-names></name><name><surname>Rahman</surname><given-names>I</given-names></name><name><surname>Block</surname><given-names>R</given-names></name><name><surname>Morris</surname><given-names>A</given-names></name><name><surname>Prestwich</surname><given-names>G</given-names></name><name><surname>Georas</surname><given-names>SN</given-names></name><article-title>Quantitative analysis of serum autotaxin levels in asthma and chronic obstructive pulmonary disease</article-title><source>American journal of respiratory and critical care medicine</source><year>2009</year><volume>179</volume><fpage>A2528</fpage></mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal"><name><surname>Xu</surname><given-names>MY</given-names></name><name><surname>Porte</surname><given-names>J</given-names></name><name><surname>Knox</surname><given-names>AJ</given-names></name><name><surname>Weinreb</surname><given-names>PH</given-names></name><name><surname>Maher</surname><given-names>TM</given-names></name><name><surname>Violette</surname><given-names>SM</given-names></name><name><surname>McAnulty</surname><given-names>RJ</given-names></name><name><surname>Sheppard</surname><given-names>D</given-names></name><name><surname>Jenkins</surname><given-names>G</given-names></name><article-title>Lysophosphatidic acid induces alphavbeta6 integrin-mediated TGF-beta activation via the LPA2 receptor and the small G protein G alpha(q)</article-title><source>The American journal of pathology</source><year>2009</year><volume>174</volume><issue>4</issue><fpage>1264</fpage><lpage>1279</lpage><pub-id pub-id-type="doi">10.2353/ajpath.2009.080160</pub-id><pub-id pub-id-type="pmid">19147812</pub-id></mixed-citation></ref></ref-list></back></article>